IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 7, Pages e1188245
Publisher
Informa UK Limited
Online
2016-05-20
DOI
10.1080/2162402x.2016.1188245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell Adjuvants
- (2016) Hadas Weinstein-Marom et al. JOURNAL OF IMMUNOTHERAPY
- Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells
- (2015) Mark P. Rubinstein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
- (2015) Karin Schilbach et al. OncoImmunology
- DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma
- (2014) Ming-Ru Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
- (2014) Shannon L. Maude et al. CANCER JOURNAL
- Deciphering the unusual HLA-A2/Melan-A/MART-1-specific TCR repertoire in humans
- (2014) Pedro Romero et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
- (2014) Matthias Wölfl et al. Nature Protocols
- The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells
- (2014) Cristina Cerboni et al. Frontiers in Immunology
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
- (2013) D. T. Teachey et al. BLOOD
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials
- (2013) Ingunn M. Stromnes et al. IMMUNOLOGICAL REVIEWS
- DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
- (2013) Lucas Ferrari de Andrade et al. IMMUNOLOGY AND CELL BIOLOGY
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
- (2013) Christel Devaud et al. OncoImmunology
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
- (2012) Shicheng Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pathogen-Specific Inflammatory Milieux Tune the Antigen Sensitivity of CD8+ T Cells by Enhancing T Cell Receptor Signaling
- (2012) Martin J. Richer et al. IMMUNITY
- Regulation of innate CD8+ T-cell activation mediated by cytokines
- (2012) B. E. Freeman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells
- (2011) C. Quintarelli et al. BLOOD
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens
- (2011) Bianca Altvater et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes
- (2011) Shicheng Yang et al. PLoS One
- IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy
- (2010) Mike W. Helms et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy
- (2010) Matthias Wölfl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inflammatory cytokines as a third signal for T cell activation
- (2010) Julie M Curtsinger et al. CURRENT OPINION IN IMMUNOLOGY
- Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45
- (2009) A.E. Saunders et al. CELLULAR SIGNALLING
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
- (2009) Tadepally Lakshmikanth et al. JOURNAL OF CLINICAL INVESTIGATION
- Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN
- (2009) Z. Xiao et al. JOURNAL OF IMMUNOLOGY
- The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro
- (2008) Stephen Blake et al. CLINICAL IMMUNOLOGY
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started